Mohamed Sewalim El-sayed Hamed
Lecturer
Omalizumab as a long-term treatment for patients with severe asthma. Is it safe? a ten-year study
The Egyptian Journal of Chest Diseases and Tuberculosis, • 2024
Publication Information
Authors
Mohamed S. Hamed, M. Adel
Keywords
Omalizumab - long-term treatment - severe asthma
Journal
The Egyptian Journal of Chest Diseases and Tuberculosis,
Publisher
The Egyptian Journal of Chest Diseases and Tuberculosis,
Volume
73
Issue
1
Pages
7-12
publication.type
International
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Omalizumab as a long-term treatment for patients with severe asthma. Is it safe? a ten-year study